A Look At Alnylam Pharmaceuticals (ALNY) Valuation After Recent Choppy Trading And Rich P/E Multiple [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
Alnylam Pharmaceuticals: Event-Triggered Stock Snapshot Alnylam Pharmaceuticals (ALNY) stock has drawn attention after recent trading moves, with investors weighing its US$320.13 last close against mixed short term returns and stronger multi year total returns. See our latest analysis for Alnylam Pharmaceuticals. Recent trading has been choppy, with a 1 day share price return of negative 3.98% and a year to date share price return of negative 20.00%. At the same time, the 1 year, 3 year, and 5 year total shareholder returns of 36.48%, 57.81%, and 132.37% indicate that, despite recent weakness, longer term momentum has been strong. If you are comparing Alnylam with other names benefiting from advances in biotech and AI driven drug development, it may be worth scanning 35 healthcare AI stocks With Alnylam trading at US$320.13, showing an indicated intrinsic discount of about 47% against a US$449.12 target, investors now face a key question: is there genuine upside left, or is
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Brown Advisory Large-Cap Growth Strategy Q1 2026 Portfolio Review [Seeking Alpha]Seeking Alpha
- Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial ResultsBusiness Wire
- Aerska Strengthens Leadership and Board with Key Appointments to Advance Systemically Delivered RNA Medicines for the Brain [Yahoo! Finance]Yahoo! Finance
- RNAi?????2035??25?6,720?????????CAGR9.30%???????????????????????? : ???????????????????? [CNET News]CNET News
- Alnylam Pharmaceuticals (ALNY) had its price target lowered by Truist Financial Corporation from $515.00 to $505.00. They now have a "buy" rating on the stock.MarketBeat
ALNY
Earnings
- 2/12/26 - Beat
ALNY
Sec Filings
- 4/7/26 - Form 4
- 4/7/26 - Form 3
- 4/6/26 - Form ARS
- ALNY's page on the SEC website